Literature DB >> 25078133

Quantification of frequent-hitter behavior based on historical high-throughput screening data.

J Willem M Nissink1, Sam Blackburn.   

Abstract

AIM: We mine historical high-throughput data to identify and characterize 'frequent hitters', hits that are potentially false-positive results.
BACKGROUND: A key problem in the field of high-throughput screening (HTS) is recognition of frequent hitters, which are false-positive or otherwise anomalous compounds that tend to crop up across many screens. Follow-up of such compounds constitutes a waste of resource and decreases efficiency.
METHODOLOGY: We describe a systematic retrospective approach to identify anomalous hitter behavior using historical screening data. We take into account the uncertainty that arises if not enough screen data are available and extend implementation to target and technology classes.
CONCLUSION: Use of the descriptor in analyzing high-throughput screen results frees up resource for follow-up of more likely true hits in the downstream hit-deconvolution cascade, thereby increasing efficiency of screen delivery. Although effective, historical data bias can affect the annotation, and we exemplify cases where this happened.

Entities:  

Mesh:

Year:  2014        PMID: 25078133     DOI: 10.4155/fmc.14.72

Source DB:  PubMed          Journal:  Future Med Chem        ISSN: 1756-8919            Impact factor:   3.808


  19 in total

1.  The impact of data integrity on decision making in early lead discovery.

Authors:  Bernd Beck; Daniel Seeliger; Jan M Kriegl
Journal:  J Comput Aided Mol Des       Date:  2015-09-26       Impact factor: 3.686

2.  Dark chemical matter as a promising starting point for drug lead discovery.

Authors:  Anne Mai Wassermann; Eugen Lounkine; Dominic Hoepfner; Gaelle Le Goff; Frederick J King; Christian Studer; John M Peltier; Melissa L Grippo; Vivian Prindle; Jianshi Tao; Ansgar Schuffenhauer; Iain M Wallace; Shanni Chen; Philipp Krastel; Amanda Cobos-Correa; Christian N Parker; John W Davies; Meir Glick
Journal:  Nat Chem Biol       Date:  2015-10-19       Impact factor: 15.040

3.  Isatins Inhibit N5-CAIR Synthetase by a Substrate Depletion Mechanism.

Authors:  Cale C Streeter; Qian Lin; Steven M Firestine
Journal:  Biochemistry       Date:  2019-04-17       Impact factor: 3.162

4.  Post-HTS case report and structural alert: Promiscuous 4-aroyl-1,5-disubstituted-3-hydroxy-2H-pyrrol-2-one actives verified by ALARM NMR.

Authors:  Jayme L Dahlin; J Willem M Nissink; Subhashree Francis; Jessica M Strasser; Kristen John; Zhiguo Zhang; Michael A Walters
Journal:  Bioorg Med Chem Lett       Date:  2015-08-10       Impact factor: 2.823

5.  Dark chemical matter in public screening assays and derivation of target hypotheses.

Authors:  Swarit Jasial; Jürgen Bajorath
Journal:  Medchemcomm       Date:  2017-10-26       Impact factor: 3.597

6.  Beyond PAINs: Chemotype Sensitivity of Protein Methyltransferases in Screens.

Authors:  Cen Gao; Brandon J Margolis; John M Strelow; Lewis R Vidler; Mary M Mader
Journal:  ACS Med Chem Lett       Date:  2015-11-19       Impact factor: 4.345

Review 7.  Mechanistic enzymology in drug discovery: a fresh perspective.

Authors:  Geoffrey A Holdgate; Thomas D Meek; Rachel L Grimley
Journal:  Nat Rev Drug Discov       Date:  2017-12-01       Impact factor: 84.694

Review 8.  Nuisance compounds in cellular assays.

Authors:  Jayme L Dahlin; Douglas S Auld; Ina Rothenaigner; Steve Haney; Jonathan Z Sexton; J Willem M Nissink; Jarrod Walsh; Jonathan A Lee; John M Strelow; Francis S Willard; Lori Ferrins; Jonathan B Baell; Michael A Walters; Bruce K Hua; Kamyar Hadian; Bridget K Wagner
Journal:  Cell Chem Biol       Date:  2021-02-15       Impact factor: 8.116

9.  PAINS in the assay: chemical mechanisms of assay interference and promiscuous enzymatic inhibition observed during a sulfhydryl-scavenging HTS.

Authors:  Jayme L Dahlin; J Willem M Nissink; Jessica M Strasser; Subhashree Francis; LeeAnn Higgins; Hui Zhou; Zhiguo Zhang; Michael A Walters
Journal:  J Med Chem       Date:  2015-02-21       Impact factor: 8.039

Review 10.  Can Invalid Bioactives Undermine Natural Product-Based Drug Discovery?

Authors:  Jonathan Bisson; James B McAlpine; J Brent Friesen; Shao-Nong Chen; James Graham; Guido F Pauli
Journal:  J Med Chem       Date:  2015-10-27       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.